Lyell Immunopharma to Present at 25th Annual Needham Virtual Healthcare Conference

The late-stage clinical company will showcase its pipeline of next-generation CAR T-cell therapies for cancer patients.

Apr. 7, 2026 at 12:03pm

Got story updates? Submit your updates here. ›

A translucent, ghostly X-ray image revealing the intricate molecular structure of a next-generation CAR T-cell therapy, conceptually illustrating the company's advanced cancer research.Lyell Immunopharma's cutting-edge CAR T-cell therapies aim to revolutionize cancer treatment through innovative molecular engineering.South San Francisco Today

Lyell Immunopharma, Inc., a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will present and participate in the 25th Annual Needham Virtual Healthcare Conference on Tuesday, April 14, 2026, at 11:00 am Eastern Time.

Why it matters

Lyell's participation in this high-profile healthcare conference signals the company's continued progress in developing innovative CAR T-cell therapies, which have shown promise in treating various types of cancer. As a late-stage clinical company, Lyell's presentation will likely provide updates on its pipeline and clinical trial progress, which could be of interest to investors, industry analysts, and the broader medical community.

The details

The live webcast of Lyell's presentation can be accessed through the Investors section of the company's website at www.lyell.com. A replay of the webcast will be available on the company's website following the presentation date.

  • The 25th Annual Needham Virtual Healthcare Conference will take place on Tuesday, April 14, 2026.
  • Lyell's presentation is scheduled for 11:00 am Eastern Time on April 14, 2026.

The players

Lyell Immunopharma, Inc.

A late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer.

Got photos? Submit your photos here. ›

The takeaway

Lyell's participation in the prestigious Needham Virtual Healthcare Conference underscores the company's progress in developing innovative CAR T-cell therapies, which have the potential to transform cancer treatment. Investors and the medical community will be closely watching for updates on Lyell's pipeline and clinical trial advancements.